COVID-19 and the second wave during autumn: preventive strategies in cardiac and thoracic surgery divisions

[1]  C. Napoli,et al.  Commentary: Urgent need for careful holistic assessment post-coronavirus disease 2019 (COVID-19) hospitalization: Crisis after crisis? , 2020, The Journal of Thoracic and Cardiovascular Surgery.

[2]  C. Napoli,et al.  Adult cardiovascular surgery and the coronavirus disease 2019 (COVID-19) pandemic: the Italian experience , 2020, Interactive cardiovascular and thoracic surgery.

[3]  A. McAlearney,et al.  Management Practices for Leaders to Promote Infection Prevention: Lessons from a Qualitative Study , 2020, American journal of infection control.

[4]  C. Napoli,et al.  Epigenetic susceptibility to severe respiratory viral infections and its therapeutic implications: a narrative review , 2020, British Journal of Anaesthesia.

[5]  C. Napoli,et al.  Cardiovascular involvement during COVID-19 and clinical implications in elderly patients. A review , 2020, Annals of Medicine and Surgery.

[6]  Nguyen H. Tran,et al.  Safety and immunogenicity of the ChAdOx1 nCoV-19 vaccine against SARS-CoV-2: a preliminary report of a phase 1/2, single-blind, randomised controlled trial , 2020, The Lancet.

[7]  J. Mascola,et al.  An mRNA Vaccine against SARS-CoV-2 — Preliminary Report , 2020, The New England journal of medicine.

[8]  C. Napoli,et al.  Immunosenescence exacerbates the COVID-19 , 2020, Archives of Gerontology and Geriatrics.

[9]  H. Balkhy,et al.  Tackling antimicrobial resistance in the COVID-19 pandemic , 2020, Bulletin of the World Health Organization.

[10]  C. Napoli,et al.  Can COVID 2019 induce a specific cardiovascular damage or it exacerbates pre-existing cardiovascular diseases? , 2020, Pathology - Research and Practice.

[11]  M. Hendaus,et al.  Covid-19 induced superimposed bacterial infection , 2020, Journal of biomolecular structure & dynamics.

[12]  N. Shah,et al.  Rates of Co-infection Between SARS-CoV-2 and Other Respiratory Pathogens. , 2020, JAMA.

[13]  C. Napoli,et al.  Clinical epigenetics and multidrug-resistant bacterial infections: host remodelling in critical illness , 2020, Epigenetics.

[14]  N. Lurie,et al.  Developing Covid-19 Vaccines at Pandemic Speed. , 2020, The New England journal of medicine.

[15]  C. Chao,et al.  Achieving “Zero” CLABSI and VAP after Sequential Implementation of Central Line Bundle and Ventilator Bundle , 2014, Infection Control & Hospital Epidemiology.